Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis

Journal of Rheumatology

Volumn 40, Issue 5, 2013, Pages 634-639

  Sulli, Alberto ^a   Ruaro, Barbara ^a   Smith, Vanessa ^b   Pizzorni, Carmen ^a   Zampogna, Giuseppe ^a   Gallo, Maurizio ^a   Cutolo, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antinuclear antibodies; Indirect immunofluorescence; Microangiopathy; Nailfold videocapillaroscopy; Scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; SCL 70 ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CAPILLAROSCOPY; CAPILLARY; CENTROMERE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; MICROANGIOPATHY; NAIL DISEASE; NAILFOLD MICROVASCULAR DAMAGE; NAILFOLD VIDEOCAPILLAROSCOPY; NUCLEOLUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS;

ANTINUCLEAR ANTIBODIES; INDIRECT IMMUNOFLUORESCENCE; MICROANGIOPATHY; NAILFOLD VIDEOCAPILLAROSCOPY; SCLERODERMA; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KAPLAN-MEIER ESTIMATE; MICROSCOPIC ANGIOSCOPY; MICROSCOPY, VIDEO; MICROVESSELS; MIDDLE AGED; NAILS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 84876892804     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121089     Document Type: Article

References (16)

1. Sulli A, Pizzorni C, Smith V, Zampogna G, Ravera F, Cutolo M. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 2012;64:821-5.
2. Ingegnoli F, Boracchi P, Gualtierotti R, Lubatti C, Meani L, Zahalkova L, et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder. Arthritis Rheum 2008;58:2174-82. (Pubitemid 351988111)
3. Cutolo M, Sulli A, Smith V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 2010;6:578-87.
4. Fleming JN, Schwartz SM. The pathology of scleroderma vascular disease. Rheum Dis Clin North Am 2008;34:41-55. (Pubitemid 351337630)
5. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-12.
6. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26. (Pubitemid 38807428)
7. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983;1:195-205. (Pubitemid 14210276)
8. Chen ZY, Silver RM, Ainsworth SK, Dobson RL, Rust P, Maricq HR. Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders. Am J Med 1984;77:812-22. (Pubitemid 15204857)
9. Bielecki M, Kowal K, Lapinska A, Bernatowicz P, Chyczewski L, Kowal-Bielecka O. Increased production of a proliferation-inducing ligand (APRIL) by peripheral blood mononuclear cells is associated with antitopoisomerase I antibody and more severe disease in systemic sclerosis. J Rheumatol 2010;37:2286-9.
10. Cavazzana I, Ceribelli A, Airo' P, Zingarelli S, Tincani A, Franceschini F. Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun Rev 2009;8:580-4.
11. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6. (Pubitemid 32660630)
12. Cutolo M. Capillaroscopy in systemic sclerosis. In: Cutolo M, editor. Atlas of capillaroscopy. Milan: Elsevier; 2010:103-13.
13. Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008;67:885-7. (Pubitemid 351829394)
14. Smith V, Pizzorni C, De Keyser F, Decuman S, Van Praet JT, Deschepper E, et al. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: A two-centre study. Ann Rheum Dis 2010;69:1092-6.
15. Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. Autoimmun Rev 2013;12:340-54.
16. Riccieri V, Germano V, Alessandri C, Vasile M, Ceccarelli F, Sciarra I, et al. More severe nailfold capillaroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Clin Exp Rheumatol 2008;26:992-7.